UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.56 -1.07 (-1.29%) GOLD FUTURES
2,302.80 -54.90 (-2.33%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
47,862.49 -2,590.22 (-5.13%)
Royalty Pharma plc (RPRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 12.68B |
| Enterprise value | 17.58B |
| Trailing P/E | 11.11 |
| Forward P/E | 8.27 |
| PEG ratio (5-yr expected) | 1.17 |
| Price/sales (ttm) | 7.20 |
| Price/book (mrq) | 1.94 |
| Enterprise value/revenue | 7.47 |
| Enterprise value/EBITDA | 9.32 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.45 |
| 52-week change 3 | -19.79% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 35.76 |
| 52-week low 3 | 25.92 |
| 50-day moving average 3 | 29.57 |
| 200-day moving average 3 | 28.78 |
Share statistics
| Avg vol (3-month) 3 | 2.83M |
| Avg vol (10-day) 3 | 2.62M |
| Shares outstanding 5 | 450.98M |
| Implied shares outstanding 6 | 597.44M |
| Float 8 | 384.42M |
| % held by insiders 1 | 3.79% |
| % held by institutions 1 | 71.62% |
| Shares short (15 Apr 2024) 4 | 14.15M |
| Short ratio (15 Apr 2024) 4 | 5.83 |
| Short % of float (15 Apr 2024) 4 | 3.31% |
| Short % of shares outstanding (15 Apr 2024) 4 | 3.17% |
| Shares short (prior month 15 Mar 2024) 4 | 12.65M |
Dividends & splits
| Forward annual dividend rate 4 | 0.84 |
| Forward annual dividend yield 4 | 2.99% |
| Trailing annual dividend rate 3 | 0.80 |
| Trailing annual dividend yield 3 | 2.84% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 31.62% |
| Dividend date 3 | 14 Jun 2024 |
| Ex-dividend date 4 | 16 May 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 48.20% |
| Operating margin (ttm) | 102.82% |
Management effectiveness
| Return on assets (ttm) | 5.62% |
| Return on equity (ttm) | 17.34% |
Income statement
| Revenue (ttm) | 2.35B |
| Revenue per share (ttm) | 5.26 |
| Quarterly revenue growth (yoy) | 5.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.5B |
| Net income avi to common (ttm) | 1.13B |
| Diluted EPS (ttm) | 2.53 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 495.31M |
| Total cash per share (mrq) | 1.11 |
| Total debt (mrq) | 6.14B |
| Total debt/equity (mrq) | 60.84% |
| Current ratio (mrq) | 7.90 |
| Book value per share (mrq) | 14.61 |
Cash flow statement
| Operating cash flow (ttm) | 2.99B |
| Levered free cash flow (ttm) | -1.25B |
© 2024 Yahoo. All rights reserved.